Onl Therapeutics Appoints Penny Fleck As Chief Development Officer
01/08/25, 6:15 PM
Location
ann arborIndustry
biopharma
health care
Position
chief development officer
ONL Therapeutics, Inc announced the appointment of Penny Fleck as chief development officer. In her new role, Ms Fleck will lead the development activities for the company’s lead asset, ONL1204 Ophthalmic Solution.
Company Info
Location
524 s. main st
ann arbor, michigan, united states
Additional Info
ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to developing first-in-class therapeutics to protect and improve the vision of patients with retinal disease. By advancing a breakthrough technology designed to protect key retinal cells from Fas-mediated cell death, ONL is pioneering a new approach to preserving vision.